Sepio Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.75M | Buy |
4,417
+665
| +18% | +$453K | 0.14% | 85 |
|
|
2026
Q1 | $2.9M | Sell |
3,752
-149
| -4% | -$114K | 0.16% | 91 |
|
|
2025
Q4 | $3.01M | Sell |
3,901
-79
| -2% | -$53.6K | 0.16% | 87 |
|
|
2025
Q3 | $2.24M | Buy |
3,980
+23
| +0.6% | +$13K | 0.13% | 98 |
|
|
2025
Q2 | $2.08M | Buy |
3,957
+568
| +17% | +$317K | 0.15% | 101 |
|
|
2025
Q1 | $2.15M | Buy |
3,389
+842
| +33% | +$579K | 0.17% | 99 |
|
|
2024
Q4 | $1.81M | Sell |
2,547
-4
| -0.2% | -$3.36K | 0.15% | 114 |
|
|
2024
Q3 | $2.68M | Sell |
2,551
-19
| -0.7% | -$21.1K | 0.21% | 87 |
|
|
2024
Q2 | $2.7M | Sell |
2,570
-19
| -0.7% | -$18.4K | 0.25% | 83 |
|
|
2024
Q1 | $2.49M | Sell |
2,589
-113
| -4% | -$107K | 0.21% | 99 |
|
|
2023
Q4 | $2.37M | Sell |
2,702
-563
| -17% | -$464K | 0.2% | 92 |
|
|
2023
Q3 | $2.69M | Sell |
3,265
-3,718
| -53% | -$2.92M | 0.23% | 95 |
|
|
2023
Q2 | $5.04M | Buy |
6,983
+68
| +1% | +$52.4K | 0.41% | 64 |
|
|
2023
Q1 | $5.68M | Sell |
6,915
-411
| -6% | -$310K | 0.52% | 50 |
|
|
2022
Q4 | $5.29M | Sell |
7,326
-1,295
| -15% | -$956K | 0.46% | 51 |
|
|
2022
Q3 | $5.94M | Sell |
8,621
-4,800
| -36% | -$3.02M | 0.59% | 37 |
|
|
2022
Q2 | $7.93M | Buy |
13,421
+5,535
| +70% | +$3.6M | 0.8% | 23 |
|
|
2022
Q1 | $5.51M | Sell |
7,886
-839
| -10% | -$531K | 0.48% | 56 |
|
|
2021
Q4 | $5.51M | Sell |
8,725
-42
| -0.5% | -$25.8K | 0.41% | 61 |
|
|
2021
Q3 | $5.31M | Sell |
8,767
-3,566
| -29% | -$2.21M | 0.44% | 54 |
|
|
2021
Q2 | $6.89M | Buy |
12,333
+2,933
| +31% | +$1.49M | 0.57% | 36 |
|
|
2021
Q1 | $4.45M | Sell |
9,400
-55
| -0.6% | -$26.8K | 0.41% | 66 |
|
|
2020
Q4 | $4.57M | Sell |
9,455
-1,528
| -14% | -$825K | 0.39% | 67 |
|
|
2020
Q3 | $6.15M | Sell |
10,983
-427
| -4% | -$259K | 0.67% | 43 |
|
|
2020
Q2 | $7.12M | Sell |
11,410
-348
| -3% | -$198K | 0.84% | 27 |
|
|
2020
Q1 | $5.75M | Buy |
11,758
+309
| +3% | +$127K | 0.76% | 35 |
|
|
2019
Q4 | $4.3M | Sell |
11,449
-1,116
| -9% | -$375K | 0.41% | 80 |
|
|
2019
Q3 | $3.49M | Buy |
12,565
+1,880
| +18% | +$556K | 0.36% | 89 |
|
|
2019
Q2 | $3.34M | Buy |
10,685
+107
| +1% | +$35.6K | 0.45% | 69 |
|
|
2019
Q1 | $4.34M | Sell |
10,578
-1,629
| -13% | -$671K | 0.59% | 45 |
|
|
2018
Q4 | $4.56M | Buy |
+12,207
| New | +$4.47M | 0.33% | 51 |
|
Other funds holding REGN
Sepio Capital's REGN Position: Q2 2026 in Review
Sepio Capital increased its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2026, buying an estimated $453K and bringing the position to 4,417 shares worth $2.75M. The position accounts for 0.14% of the portfolio, ranked #85.
Sepio Capital first reported a position in REGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.93M in Q2 2022. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Sepio Capital held 4,417 shares of Regeneron Pharmaceuticals worth $2.75M as of Q2 2026.
- Sepio Capital bought 665 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $453K.
- Regeneron Pharmaceuticals made up 0.14% of Sepio Capital's portfolio in Q2 2026, its #85 holding.
- Sepio Capital first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
- Sepio Capital's Regeneron Pharmaceuticals position peaked at $7.93M in Q2 2022.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.